April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Vivek Subbiah: Editorial on Emerging KRAS-Targeted Therapies Published in ASCO’s JCO OP
Apr 10, 2025, 10:57

Vivek Subbiah: Editorial on Emerging KRAS-Targeted Therapies Published in ASCO’s JCO OP

Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared on LinkedIn shared a recent post by Andrew J. Pellatt et al. published in JCO Oncology Practice.

“With so many KRAS targeted drugs entering clinical trials pleased to share our editorial in American Society of Clinical Oncology (ASCO) journal JCO OP

Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer.”

Authors: Andrew J. Pellatt et al.

Vivek Subbiah